Core Viewpoint - Shanghai Shengsheng has submitted its listing application to the Hong Kong Stock Exchange, with CICC and Guojin Securities (Hong Kong) as joint sponsors. The company specializes in integrated temperature-controlled supply chain services for the pharmaceutical and life sciences industry, covering preclinical research, clinical trials, and post-market commercialization [1] Company Summary - Shanghai Shengsheng is the leading provider of temperature-controlled supply chain services in the pharmaceutical and life sciences sector in China, ranked first by revenue for 2024 according to Frost & Sullivan [1] - The company is the only Chinese enterprise among the top ten global providers of clinical trial temperature-controlled supply chain services, ranked ninth globally with a market share of 1.5% for 2024 [1] - The services offered by the company include project management, clinical packaging and labeling, temperature-controlled packaging, logistics and storage, drug recovery and destruction, bonded warehousing, import and export agency, customs clearance, direct delivery to patients, and biological sample management [1] - As of January 5, 2026, the company has served over 7,000 clients and operates clinical drug warehouses and biological sample banks in Shanghai, Beijing, and Guangzhou, with more than 130 operational sites providing efficient delivery services [1] Industry Summary - The global market for temperature-controlled supply chain services for commercial medical products is projected to grow from RMB 127.1 billion in 2020 to RMB 174.8 billion in 2024, with a compound annual growth rate (CAGR) of 8.3% [2] - The Chinese market is expected to grow from RMB 16.8 billion to RMB 22.9 billion during the same period, with projections to expand to RMB 38.6 billion by 2030 [2] - The share of cold chain categories in the commercial pharmaceuticals and medical products market in China continues to increase, driving demand for compliant cold chain distribution, professional storage, and integrated distribution services [2]
上海生生递表港交所 中金公司、国金证券(香港)为联席保荐人